Investing
Top Day Trader Alert Stocks (CIT, C, GS, JNJ, NVAX, VNDA, VASC)
Published:
Last Updated:
These are this morning’s top day trader alert stocks. We have more detailed price and volume analysis on each stock link over at VSInvestor.com:
CIT Group Inc. (NYSE: CIT) is getting crushed and is back under $1.00 on its news this morning.
Goldman Sachs Group Inc. (NYSE: GS) is down almost 2% on the Meredith Whitney downgrade.
Citigroup, Inc. (NYSE: C) is up marginally despite an analyst “BUY” recommendation.
Johnson & Johnson (NYSE: JNJ) is down 2.5% at $60.95 despite beating earnings because revenues were light and ‘raised guidance’ looks effectively in-line.
Novavax, Inc. (NASDAQ: NVAX) is rising over 7% on a small NIH grant.
Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) is one of this morning’s top gainers on a a Novartis pact.
Vascular Solutions, Inc. (NASDAQ: VASC) is another top percentage gainer on FDA marketing approval for its next-generation Guardian II Hemostasis valve.
You can join our open email distribution list to get updates each morning on analyst upgrades and downgrades, top day trader alerts, IPO’s and secondary offerings, Warren Buffett and other guru activity, M&A and more.
JON C. OGG
OCTOBER 13, 2009
The thought of burdening your family with a financial disaster is most Americans’ nightmare. However, recent studies show that over 100 million Americans still don’t have proper life insurance in the event they pass away.
Life insurance can bring peace of mind – ensuring your loved ones are safeguarded against unforeseen expenses and debts. With premiums often lower than expected and a variety of plans tailored to different life stages and health conditions, securing a policy is more accessible than ever.
A quick, no-obligation quote can provide valuable insight into what’s available and what might best suit your family’s needs. Life insurance is a simple step you can take today to help secure peace of mind for your loved ones tomorrow.
Click here to learn how to get a quote in just a few minutes.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.